173 related articles for article (PubMed ID: 35845220)
1. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy following anti-CD19 CAR-T therapy: a case report.
Mackenzie S; Shafat M; Roddy H; Hyare H; Neill L; Marzolini MAV; Gilhooley M; Marafioti T; Kara E; Sanchez E; Rees J; Lynch DS; Thomson K; Ardeshna KM; Laurence A; Peggs KS; O'Reilly M; Roddie C
EJHaem; 2021 Nov; 2(4):848-853. PubMed ID: 35845220
[TBL] [Abstract][Full Text] [Related]
2. Pembrolizumab Treatment for Progressive Multifocal Leukoencephalopathy.
Cortese I; Muranski P; Enose-Akahata Y; Ha SK; Smith B; Monaco M; Ryschkewitsch C; Major EO; Ohayon J; Schindler MK; Beck E; Reoma LB; Jacobson S; Reich DS; Nath A
N Engl J Med; 2019 Apr; 380(17):1597-1605. PubMed ID: 30969503
[TBL] [Abstract][Full Text] [Related]
3. Pembrolizumab for the treatment of Progressive Multifocal Leukoencephalopathy (PML) in a patient with AIDS: A case report and literature review.
Chatterjee T; Roy M; Lin RC; Almoujahed MO; Ahmad S
IDCases; 2022; 28():e01514. PubMed ID: 35637642
[TBL] [Abstract][Full Text] [Related]
4. Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma.
Ahrendsen JT; Sehgal K; Sarangi S; Uhlmann EJ; Varma H; Arnason J; Avigan D
J Hematol; 2021 Oct; 10(5):212-216. PubMed ID: 34804310
[TBL] [Abstract][Full Text] [Related]
5. Pembrolizumab for treatment of progressive multifocal leukoencephalopathy in primary immunodeficiency and/or hematologic malignancy: a case series of five patients.
Volk T; Warnatz K; Marks R; Urbach H; Schluh G; Strohmeier V; Rojas-Restrepo J; Grimbacher B; Rauer S
J Neurol; 2022 Feb; 269(2):973-981. PubMed ID: 34196768
[TBL] [Abstract][Full Text] [Related]
6. Sequential treatment of progressive multifocal leukoencephalopathy with intravenous immunoglobulins and pembrolizumab.
Boesl F; Allers K; Herm J; Scheider T; Franke C
J Neurovirol; 2022 Apr; 28(2):335-338. PubMed ID: 35320511
[TBL] [Abstract][Full Text] [Related]
7. Late occurrence of progressive multifocal leukoencephalopathy after anti-CD19 chimeric antigen receptor T-cell therapy.
Mian A; Andrapalliyal N; Weathers AL; Pohlman B; Hill BT
Eur J Haematol; 2021 Apr; 106(4):584-588. PubMed ID: 33459429
[TBL] [Abstract][Full Text] [Related]
8. Probable progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome with immunosuppressant dose reduction following lung transplantation: a case report and literature review.
Ishii K; Yamamoto F; Homma S; Okada Y; Nakamichi K; Saijo M; Tamaoka A
BMC Neurol; 2019 Oct; 19(1):263. PubMed ID: 31672142
[TBL] [Abstract][Full Text] [Related]
9. Progressive multifocal leukoencephalopathy and immune reconstitution inflammatory syndrome (IRIS).
Bauer J; Gold R; Adams O; Lassmann H
Acta Neuropathol; 2015 Dec; 130(6):751-64. PubMed ID: 26323992
[TBL] [Abstract][Full Text] [Related]
10. PD-1-inhibitor pembrolizumab for treatment of progressive multifocal leukoencephalopathy.
Möhn N; Wattjes MP; Adams O; Nay S; Tkachenko D; Salge F; Heine J; Pars K; Höglinger G; Respondek G; Stangel M; Skripuletz T; Jacobs R; Sühs KW
Ther Adv Neurol Disord; 2021; 14():1756286421993684. PubMed ID: 34035834
[TBL] [Abstract][Full Text] [Related]
11. Progressive multifocal leukoencephalopathy associated with a lymphoproliferative disorder treated with pembrolizumab.
Holmes A; Wellings T; Walsh O; Rowlings P
J Neurovirol; 2020 Dec; 26(6):961-963. PubMed ID: 32910430
[TBL] [Abstract][Full Text] [Related]
12. Pembrolizumab treatment of inflammatory progressive multifocal leukoencephalopathy: a report of two cases.
Darcy S; Alexander M; McCarthy A; O'Dowd S
J Neurovirol; 2022 Feb; 28(1):145-150. PubMed ID: 34874539
[TBL] [Abstract][Full Text] [Related]
13. Progressive Multifocal Leukoencephalopathy Treated by Immune Checkpoint Inhibitors.
Boumaza X; Bonneau B; Roos-Weil D; Pinnetti C; Rauer S; Nitsch L; Del Bello A; Jelcic I; Sühs KW; Gasnault J; Goreci Y; Grauer O; Gnanapavan S; Wicklein R; Lambert N; Perpoint T; Beudel M; Clifford D; Sommet A; Cortese I; Martin-Blondel G;
Ann Neurol; 2023 Feb; 93(2):257-270. PubMed ID: 36151879
[TBL] [Abstract][Full Text] [Related]
14. Severe Progressive Multifocal Leukoencephalopathy (PML) and Spontaneous Immune Reconstitution Inflammatory Syndrome (IRIS) in an Immunocompetent Patient.
Krey L; Raab P; Sherzay R; Berding G; Stoll M; Stangel M; Wegner F
Front Immunol; 2019; 10():1188. PubMed ID: 31191548
[No Abstract] [Full Text] [Related]
15. Progressive multifocal leukoencephalopathy in systemic lupus erythematosus managed with pembrolizumab: A case report with literature review.
Lan TY; Chen YS; Cheng CF; Huang ST; Shen CY; Hsu PN
Lupus; 2021 Oct; 30(11):1849-1855. PubMed ID: 34325541
[TBL] [Abstract][Full Text] [Related]
16. Pembrolizumab for the treatment of progressive multifocal leukoencephalopathy in China.
Fan S; Liu M; Bai L; Chen S; Hou B; Lin N; Yuan J; Mao C; Niu J; Ren H; Zhao Y; Zhang Z; Zhu Y; Peng B; Guan H
J Neurovirol; 2023 Dec; 29(6):692-698. PubMed ID: 37898569
[TBL] [Abstract][Full Text] [Related]
17. Checkpoint inhibitors for the treatment of JC virus-related progressive multifocal leukoencephalopathy.
Beck ES; Cortese I
Curr Opin Virol; 2020 Feb; 40():19-27. PubMed ID: 32279025
[TBL] [Abstract][Full Text] [Related]
18. Immune checkpoint inhibitors for progressive multifocal leukoencephalopathy: a new gold standard?
Roos-Weil D; Weiss N; Guihot A; Uzunov M; Bellanger A; Eymard B; Saadoun D; Houillier C; Idbaih A; Demeret S; Deback C; Leblond V; Galanaud D; Shor N; Pourcher V
J Neurol; 2021 Jul; 268(7):2458-2465. PubMed ID: 33515299
[TBL] [Abstract][Full Text] [Related]
19. Progressive multifocal leukoencephalopathy after CAR T therapy.
Sdrimas K; Diaz-Paez M; Camargo JF; Lekakis LJ
Int J Hematol; 2020 Jul; 112(1):118-121. PubMed ID: 32125605
[TBL] [Abstract][Full Text] [Related]
20. Use of Pembrolizumab for Treatment of Progressive Multifocal Leukoencephalopathy in People Living with HIV.
Pinnetti C; Cimini E; Vergori A; Mazzotta V; Grassi G; Mondi A; Forbici F; Amendola A; Grisetti S; Baldini F; Candela C; Casetti R; Campioni P; Capobianchi MR; Agrati C; Antinori A
Viruses; 2022 May; 14(5):. PubMed ID: 35632711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]